Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M, Mokhtarzadeh A, Aghebati-Maleki L, Mansoori B, Mohammadi A, Safaei S, Asadzadeh Z, Hajiasgharzadeh K, Khaze Shahgoli V, Baradaran B. Aghajani M, et al. Among authors: safaei s. Mol Biol Rep. 2020 May;47(5):3691-3703. doi: 10.1007/s11033-020-05411-9. Epub 2020 Apr 3. Mol Biol Rep. 2020. PMID: 32246247
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines.
Lotfinejad P, Kazemi T, Safaei S, Amini M, Roshani Asl E, Baghbani E, Sandoghchian Shotorbani S, Jadidi Niaragh F, Derakhshani A, Abdoli Shadbad M, Silvestris N, Baradaran B. Lotfinejad P, et al. Among authors: safaei s. Biomed Pharmacother. 2021 Jun;138:111436. doi: 10.1016/j.biopha.2021.111436. Epub 2021 Mar 2. Biomed Pharmacother. 2021. PMID: 33667790 Free article.
Targeting ROCK signaling in health, malignant and non-malignant diseases.
Shahbazi R, Baradaran B, Khordadmehr M, Safaei S, Baghbanzadeh A, Jigari F, Ezzati H. Shahbazi R, et al. Among authors: safaei s. Immunol Lett. 2020 Mar;219:15-26. doi: 10.1016/j.imlet.2019.12.012. Epub 2020 Jan 3. Immunol Lett. 2020. PMID: 31904392 Review.
PD-1/PD-L1 axis importance and tumor microenvironment immune cells.
Lotfinejad P, Kazemi T, Mokhtarzadeh A, Shanehbandi D, Jadidi Niaragh F, Safaei S, Asadi M, Baradaran B. Lotfinejad P, et al. Among authors: safaei s. Life Sci. 2020 Oct 15;259:118297. doi: 10.1016/j.lfs.2020.118297. Epub 2020 Aug 19. Life Sci. 2020. PMID: 32822718 Review.
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
Asadzadeh Z, Mansoori B, Mohammadi A, Kazemi T, Mokhtarzadeh A, Shanehbandi D, Hemmat N, Derakhshani A, Brunetti O, Safaei S, Aghajani M, Najafi S, Silvestris N, Baradaran B. Asadzadeh Z, et al. Among authors: safaei s. Biomed Pharmacother. 2021 May;137:111364. doi: 10.1016/j.biopha.2021.111364. Epub 2021 Feb 13. Biomed Pharmacother. 2021. PMID: 33592546 Free article.
108 results